Noreen Gleeson
Papers
1
Total Citations
26
H-Index
1
About
Noreen Gleeson is a leading gynecologic oncologist whose research has fundamentally reshaped surgical standards for early-stage cervical cancer. Her work centers on optimizing treatment to reduce morbidity without compromising oncologic outcomes. Gleeson’s landmark contribution is the SHAPE trial, a pivotal international phase III randomized study comparing radical hysterectomy with pelvic node dissection versus simple hysterectomy in patients with low-risk early-stage cervical cancer. This Gynecologic Cancer Intergroup study, led by the Canadian Cancer Trials Group (CCTG CX.5-SHAPE), demonstrated that less radical surgery is safe and associated with significantly less morbidity—a paradigm shift that has directly influenced global clinical guidelines. The trial’s 2023 presentation has already garnered 26 citations, reflecting its immediate impact. By providing high-level evidence that simple hysterectomy is non-inferior for carefully selected patients, Gleeson has empowered surgeons to offer less invasive, function-preserving treatment. Her work exemplifies how rigorous clinical trials can translate into meaningful improvements in patients’ quality of life, cementing her reputation as a transformative figure in gynecologic oncology.
Research Focus
Key Achievements
Top Papers
- 1